ModEx (Modular Expression) is an innovative biotechnology company developing cutting-edge multi-specific antibody and protein therapeutics utilizing proprietary modular engineering platforms. By combining multiple therapeutic mechanisms into single, highly stable molecules, ModEx aims to transform treatments within oncology, infectious diseases, and complex immune disorders.
Subscribe to our newsletter
Subscribe to receive the latest news and innovations straight to your inbox.
Your subscription could not be saved. Please try again.
We use cookies for various purposes including to make your experience of our website better. Please confirm below that you consent to our use of non-essential cookies in accordance with our cookies policy. Click here to access our cookies policy and find out more about our cookie use and how to disable cookies.